Minimum Variance and VOQL Chain Sampling Plans–ChSP-4(c1,c2)

Vidya, R.

doi:10.1080/03610910601096585

Cited by 4 publications

(1 citation statement)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Any safety standard is effective only if it is way of its realization, i.e., there is hardware-realized methods of the inspection of separate particles, but SPM or TEM methods contradicts to common practice of outgoing inspection in the large-scale manufacturing. Outgoing inspection must be focused on the control of a product massif as a whole and cannot be founded on a search for single particles with uncertain characteristics admits other particles similar to it [22]. Therefore the adequate method of outgoing inspection in the large-scale manufacturing of nanoparticles must correspond to conflicting demands: on the one hand, it must inspect a massif as a whole, but on the other hand, reveal single particles with particular characteristics.…”

Section: Microscopy In Nanoparticles Inspectionmentioning

confidence: 99%

As Could We Assure Safety in Large-Scale Manufacturing of Nanoparticles for the Biomedical Use

Maksimov¹,

Maksimov²,

Soukhov³

2011

JBNB

View full text Add to dashboard Cite

Nanoparticles provide great advantages but also great risks. Risks associating with nanoparticles are the problem of all technologies, but they increase in many times in nanotechnologies. Adequate methods of outgoing production inspection are necessary to solve the problem of risks, and the inspection must be based on the safety standard. Existing safety standard results from a principle of “maximum permissible concentrations or MPC”. This principle is not applicable to nanoparticles, but a safety standard reflecting risks inherent in nanoparticles doesn’t exist. Essence of the risks is illustrated by the example from pharmacology, since its safety assurance is conceptually based on MPC and it has already come against this problem. Possible formula of safety standard for nanoparticles is reflected in many publications, but conventional inspection methods cannot provide its realization, and this gap is an obstacle to assumption of similar formulas. Therefore the development of nanoparticle industry as a whole (also development of the pharmacology in particular) is impossible without the creation of an adequate inspection method. There are suggested new inspection methods founded on the new physical principle and satisfying to the adequate safety standard for nanoparticles. These methods demonstrate that creation of the adequate safety standard and the outgoing production inspection in a large-scale manufacturing of nanoparticles are the solvable problems. However there is a great distance between the physical principle and its hardware realization, and a transition from the principle to the hardware demands great intellectual and material costs. Therefore it is desirable to call attention of the public at large to the necessity of urgent expansions of investigations associated with outgoing inspections in nanoparticles technologies. It is necessary also to attract attention, first, of representatives of state structures controlling approvals of the adequate safety standard to this problem, since it is impossible to compel producers providing the safety without the similar standard, and, second, of leaders of pharmacological industry, since their industry already entered into the nanotechnology era, and they have taken an interest in a forthcoming development of inspection methods

show abstract

Section: Microscopy In Nanoparticles Inspectionmentioning

confidence: 99%